These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 24062992)

  • 1. Endogenous retroviruses as targets for antitumor immunity in renal cell cancer and other tumors.
    Cherkasova E; Weisman Q; Childs RW
    Front Oncol; 2013 Sep; 3():243. PubMed ID: 24062992
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inactivation of the von Hippel-Lindau tumor suppressor leads to selective expression of a human endogenous retrovirus in kidney cancer.
    Cherkasova E; Malinzak E; Rao S; Takahashi Y; Senchenko VN; Kudryavtseva AV; Nickerson ML; Merino M; Hong JA; Schrump DS; Srinivasan R; Linehan WM; Tian X; Lerman MI; Childs RW
    Oncogene; 2011 Nov; 30(47):4697-706. PubMed ID: 21602888
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human endogenous retroviruses and cancer prevention: evidence and prospects.
    Cegolon L; Salata C; Weiderpass E; Vineis P; Palù G; Mastrangelo G
    BMC Cancer; 2013 Jan; 13():4. PubMed ID: 23282240
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contribution of Human Retroviruses to Disease Development-A Focus on the HIV- and HERV-Cancer Relationships and Treatment Strategies.
    Liu CH; Grandi N; Palanivelu L; Tramontano E; Lin LT
    Viruses; 2020 Aug; 12(8):. PubMed ID: 32759845
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human Endogenous Retroviruses Are Ancient Acquired Elements Still Shaping Innate Immune Responses.
    Grandi N; Tramontano E
    Front Immunol; 2018; 9():2039. PubMed ID: 30250470
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Digital expression profiles of human endogenous retroviral families in normal and cancerous tissues.
    Stauffer Y; Theiler G; Sperisen P; Lebedev Y; Jongeneel CV
    Cancer Immun; 2004 Feb; 4():2. PubMed ID: 14871062
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human endogenous retroviruses and cancer.
    Gonzalez-Cao M; Iduma P; Karachaliou N; Santarpia M; Blanco J; Rosell R
    Cancer Biol Med; 2016 Dec; 13(4):483-488. PubMed ID: 28154780
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of an Immunogenic HERV-E Envelope with Selective Expression in Clear Cell Kidney Cancer.
    Cherkasova E; Scrivani C; Doh S; Weisman Q; Takahashi Y; Harashima N; Yokoyama H; Srinivasan R; Linehan WM; Lerman MI; Childs RW
    Cancer Res; 2016 Apr; 76(8):2177-85. PubMed ID: 26862115
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HIV infection and HERV expression: a review.
    van der Kuyl AC
    Retrovirology; 2012 Jan; 9():6. PubMed ID: 22248111
    [TBL] [Abstract][Full Text] [Related]  

  • 10. T cell responses to human endogenous retroviruses in HIV-1 infection.
    Garrison KE; Jones RB; Meiklejohn DA; Anwar N; Ndhlovu LC; Chapman JM; Erickson AL; Agrawal A; Spotts G; Hecht FM; Rakoff-Nahoum S; Lenz J; Ostrowski MA; Nixon DF
    PLoS Pathog; 2007 Nov; 3(11):e165. PubMed ID: 17997601
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Systematic Review of Expression and Immunogenicity of Human Endogenous Retroviral Proteins in Cancer and Discussion of Therapeutic Approaches.
    Müller MD; Holst PJ; Nielsen KN
    Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163254
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endogenous retroviral signatures predict immunotherapy response in clear cell renal cell carcinoma.
    Smith CC; Beckermann KE; Bortone DS; De Cubas AA; Bixby LM; Lee SJ; Panda A; Ganesan S; Bhanot G; Wallen EM; Milowsky MI; Kim WY; Rathmell WK; Swanstrom R; Parker JS; Serody JS; Selitsky SR; Vincent BG
    J Clin Invest; 2018 Nov; 128(11):4804-4820. PubMed ID: 30137025
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human endogenous retroviruses and cancer: causality and therapeutic possibilities.
    Mullins CS; Linnebacher M
    World J Gastroenterol; 2012 Nov; 18(42):6027-35. PubMed ID: 23155332
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of endogenous retroviruses-K in human cancer.
    Salavatiha Z; Soleimani-Jelodar R; Jalilvand S
    Rev Med Virol; 2020 Nov; 30(6):1-13. PubMed ID: 32734655
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypermutation of an ancient human retrovirus by APOBEC3G.
    Lee YN; Malim MH; Bieniasz PD
    J Virol; 2008 Sep; 82(17):8762-70. PubMed ID: 18562521
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HERV-K(HML-2), the Best Preserved Family of HERVs: Endogenization, Expression, and Implications in Health and Disease.
    Hohn O; Hanke K; Bannert N
    Front Oncol; 2013 Sep; 3():246. PubMed ID: 24066280
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expressional activation and functional roles of human endogenous retroviruses in cancers.
    Zhang M; Liang JQ; Zheng S
    Rev Med Virol; 2019 Mar; 29(2):e2025. PubMed ID: 30614117
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human endogenous retroviruses in cancer: Expression, regulation and function.
    Gao Y; Yu XF; Chen T
    Oncol Lett; 2021 Feb; 21(2):121. PubMed ID: 33552242
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HERV-K-specific T cells eliminate diverse HIV-1/2 and SIV primary isolates.
    Jones RB; Garrison KE; Mujib S; Mihajlovic V; Aidarus N; Hunter DV; Martin E; John VM; Zhan W; Faruk NF; Gyenes G; Sheppard NC; Priumboom-Brees IM; Goodwin DA; Chen L; Rieger M; Muscat-King S; Loudon PT; Stanley C; Holditch SJ; Wong JC; Clayton K; Duan E; Song H; Xu Y; SenGupta D; Tandon R; Sacha JB; Brockman MA; Benko E; Kovacs C; Nixon DF; Ostrowski MA
    J Clin Invest; 2012 Dec; 122(12):4473-89. PubMed ID: 23143309
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human endogenous retroviruses and their implication for immunotherapeutics of cancer.
    Attermann AS; Bjerregaard AM; Saini SK; Grønbæk K; Hadrup SR
    Ann Oncol; 2018 Nov; 29(11):2183-2191. PubMed ID: 30239576
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.